Global Ketorolac Injection Market Growth 2025-2031

The global Ketorolac Injection market size is predicted to grow from US$ 962 million in 2025 to US$ 1134 million in 2031; it is expected to grow at a CAGR of 2.8% from 2025 to 2031.

Ketorolac injection is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.

Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.

LP Information, Inc. (LPI) ' newest research report, the “Ketorolac Injection Industry Forecast” looks at past sales and reviews total world Ketorolac Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Ketorolac Injection sales for 2025 through 2031. With Ketorolac Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ketorolac Injection industry.

This Insight Report provides a comprehensive analysis of the global Ketorolac Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ketorolac Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ketorolac Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ketorolac Injection and breaks down the forecast by Concentration, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ketorolac Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Ketorolac Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Concentration:

15mg/ml

30mg/ml

Segmentation by Application:

Hospital

Clinics

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Pfizer

Fresenius Kabi

Fosun Pharma (Gland Pharma)

Sagent Pharmaceuticals

Hikma

Lunan Pharma

Alvogen

Chengdu Brilliant Pharmaceuticals

Athenex

Sichuan Medcalo

Julphar Bangladesh Ltd.

Yung Shin Pharm

Tianjin Chase Sun Pharmaceutical

ZISKA Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ketorolac Injection market?

What factors are driving Ketorolac Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ketorolac Injection market opportunities vary by end market size?

How does Ketorolac Injection break out by Concentration, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.